Supplementary Fig. 1 .

Model of resistance to RAF inhibitors caused by splicing variants of BRAFV600E that lack the RASbinding domain a b Supplementary Fig 2 Effects of vemurafenib on ERK pathway activation and survival in Parental SKMEL239 cells and the

Embed this Presentation

Download Notice

Download Presentation The PPT/PDF document "Supplementary Fig. 1 ." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.